Literature DB >> 6732231

Size and stability of a naturally occurring virus inhibitor.

D H Coppenhaver, J L Baron, M L McKerlie, J Sabados, S Baron.   

Abstract

We recently described a virus inhibitor (contact-blocking virus inhibitor) which was produced spontaneously by untransformed human and murine cells in tissue culture (S. Baron and L. McKerlie , Infect. Immun . 32:449-453, 1981). This contact-blocking virus inhibitor was characterized by broad antiviral activity, high potency, and reversible inhibition of viral attachment. Unlike interferon, the antiviral activity of the contact-blocking virus inhibitor is not species specific. An inhibitor with similar properties can also be demonstrated in many body fluids and surface secretions. We report here studies on the stability of the antiviral species which indicate that it is resistant to denaturation by heat (100 degrees C), acid (pH 2), and alkali (pH 12). The antiviral activity against all viruses tested resides in a low-molecular-weight molecule. The range of characteristics so far determined for the contact-blocking virus inhibitor distinguishes it from other virus inhibitors reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732231      PMCID: PMC185606          DOI: 10.1128/AAC.25.5.646

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins.

Authors:  J C Leong; J P Kane; O Oleszko; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

2.  Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera.

Authors:  J A Levy; J N Ihle; O Oleszko; R D Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

Review 3.  Serum inhibitors of myxoviruses.

Authors:  O Krizanová; V Rathová
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

4.  Antiviral activity in milk of possible clinical importance.

Authors:  T H Matthews; C D Nair; M K Lawrence; D A Tyrrell
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

5.  Cell-produced viral inhibitor: possible mechanism of action and chemical composition.

Authors:  T K Hughes; J E Blalock; M L McKerlie; S Baron
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Broadly active inhibitor of viruses spontaneously produced by many cell types in culture.

Authors:  S Baron; L McKerlie
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Effect of antiviral lipids, heat, and freezing on the activity of viruses in human milk.

Authors:  J K Welsh; M Arsenakis; R J Coelen; J T May
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

8.  A lipid inhibitor of dengue virus in human colostrum and milk; with a note on the absence of anti-dengue secretory antibody.

Authors:  W A Falkler; A R Diwan; S B Halstead
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

9.  Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle.

Authors:  P Gupta; J F Ferrer
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

10.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

View more
  4 in total

1.  An influenza virus inhibitor that acts late in the replication cycle.

Authors:  G Antonelli; F Dianzani; D H Coppenhaver; S Baron; P Calandra; G Folchitto
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

2.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 3.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

Review 4.  Recently described innate broad spectrum virus inhibitors.

Authors:  S Baron; D Niesel; I P Singh; L McKerlie; J Poast; A Chopra; G Antonelli; F Dianzani; D H Coppenhaver
Journal:  Microb Pathog       Date:  1989-10       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.